Longer overall survival in a patient with advanced non-small cell lung cancer treated with Chinese medicine and chemotherapy
Back to article page
OriginalPaper|Updated:2021-08-27
|
Longer overall survival in a patient with advanced non-small cell lung cancer treated with Chinese medicine and chemotherapy
Longer overall survival in a patient with advanced non-small cell lung cancer treated with Chinese medicine and chemotherapy
中国结合医学杂志(英文版)2012年18卷第8期 页码:626-628
Affiliations:
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Integration of Traditional Chinese and Western Medicine, Peking University School of Oncology, Beijing Cancer Hospital and Institute,Beijing,China
Chen, Yz., Li, Zd., Zhou, N. et al. Longer overall survival in a patient with advanced non-small cell lung cancer treated with Chinese medicine and chemotherapy., Chin. J. Integr. Med. 18, 626–628 (2012). https://doi.org/10.1007/s11655-012-1171-2
Yan-zhi Chen, Zhan-dong Li, Ning Zhou, et al. Longer overall survival in a patient with advanced non-small cell lung cancer treated with Chinese medicine and chemotherapy[J]. Chinese Journal of Integrative Medicine, 2012,18(8):626-628.
Chen, Yz., Li, Zd., Zhou, N. et al. Longer overall survival in a patient with advanced non-small cell lung cancer treated with Chinese medicine and chemotherapy., Chin. J. Integr. Med. 18, 626–628 (2012). https://doi.org/10.1007/s11655-012-1171-2DOI:
Yan-zhi Chen, Zhan-dong Li, Ning Zhou, et al. Longer overall survival in a patient with advanced non-small cell lung cancer treated with Chinese medicine and chemotherapy[J]. Chinese Journal of Integrative Medicine, 2012,18(8):626-628. DOI: 10.1007/s11655-012-1171-2.
Longer overall survival in a patient with advanced non-small cell lung cancer treated with Chinese medicine and chemotherapy
Walker S. Updates in non-small cell lung cancer. Clin J Oncol Nurs 2008;12:587–596.
Scagliotti GV, De Marinis F, Rinaldi M, Crino L, Gridelli C, Ricci S, et al. Phase III randomized trial comparing three platinum-based doublets in advanced non-small cell lung cancer. J Clin Oncol 2002;20:4285–4291.
Rosell R, Moran T, Queralt C, Porta R, Cardenal F, Camps C, et al. Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med 2009;361:958–967.
Chen YZ, Li ZD, Gao F, Zhang Y, Sun H, Li PP. Effects of combined Chinese drugs and chemotherapy in treating advanced non-small cell lung cancer. Chin J Integr Med 2009;15:415–419.
Chen YZ, Di LJ, Zhang SL, Chen MS, Sun H, Gao F, et al. The randomized, multicenter, controlled clinic trail for treating advanced non-small cell lung cancer with combined traditional Chinese medicine and vinorelbine (Navelbine, NVB) plus cisplatin (DDP) chemotherapy. Chin J Lung Cancer (Chin) 2008;11:441–444.
Li HJ, Wang H, Fang QH, Zhang GQ. Effects of Kanglaite on apoptosis and apoptotic protein procaspase-3 and caspase-9 expression in hepatic carcinoma BEL-7404 cells. Tumor (Chin) 2010;30:740–743.
Effect of Sanqi Oral Liquid (三芪口服液) on the expressions of CD4+, CD8+ and CD68+ cells in 5/6 nephrectomized rats with chronic renal failure
Effects of Astragalus membranaceus in promoting T-helper cell type 1 polarization and interferon-γ production by up-regulating T-bet expression in patients with asthma
Study on diagnosis and treatment of infectious multiple organ dysfunction syndrome by integrated traditional Chinese and Western medicine
Effects of astragalus membranaceus on urinary endothelin in patients with incipient diabetic nephropathy
Modified buyang huanwu decoction in treating 65 patients of renal syndrome hemorrhagic fever
相关作者
暂无数据
相关机构
Guangzhou University of Chinese Medicine
Pharmaceutical Manufacturing Section, Guangdong Provincial Hospital of Traditional Chinese Medicine
Epidemiological Teaching and Research Section, Guangdong Provincial Hospital of Traditional Chinese Medicine
Animal Laboratory Center, Guangdong Provincial Hospital of Traditional Chinese Medicine
Clinical Laboratory, Guangdong Provincial Hospital of Traditional Chinese Medicine